Movement Disorders

Splash Beverage Acquires Global Rights to CannEpil Therapy

FORT LAUDERDALE, Fla., July 7, 2026 Splash Beverage Group, Inc. has announced the acquisition of exclusive global licensing rights...

By cGxPwire Editor
July 8, 2026

.edu

APDA Launches Mental Health Training for Parkinson’s Care

NEW YORK, July 7, 2026 The American Parkinson Disease Association (APDA) has announced the launch of “Bridging Mental Health...

By cGxPwire Editor
July 8, 2026

Pharma

Merz Therapeutics and Teijin Secure Japan Approval for XEOMIN®

TOKYO, Japan and FRANKFURT, Germany, June 19, 2026 Teijin Pharma Limited and Merz Therapeutics GmbH have announced that Japan’s...

By cGxPwire Editor
June 22, 2026

Bio-Pharma

Neurocrine Biosciences Reports New INGREZZA Data in Tardive Dyskinesia

SAN DIEGO, June 8, 2026 Neurocrine Biosciences announced new clinical findings demonstrating the long-term effectiveness of INGREZZA® (valbenazine) capsules...

By cGxPwire Editor
June 10, 2026

M&A

Galmed to Acquire Colospan in Major GI MedTech Expansion

RAMAT GAN, Israel – June 8, 2026 Galmed Pharmaceuticals has entered into a definitive agreement to acquire Colospan Ltd.,...

By cGxPwire Editor
June 9, 2026

Find Jobs Across Pharma, Biotech & Life Sciences

Discover verified job opportunities from top companies worldwide. Apply easily and grow your career in the life sciences industry.

Pharma

Neurocrine Presents New INGREZZA Data Showing Rapid Improvements in Tardive Dyskinesia

SAN DIEGO, California, USA – June 8, 2026 Neurocrine Biosciences has presented new clinician-reported data demonstrating meaningful functional, physical,...